Matches in Nanopublications for { ?s ?p "[EXPERIMENTAL TECHNIQUE: Immunostaining for pSTAT3, TGF-alpha, EGFR, and GRPR was done in two SCCHN cohorts (cohort 1, 61 tumors; cohort 2, 69 paired primary tumors and lymph node metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP804315.RAqIHNJK_f1OXHT2VyycaFEzoDxwsOaJtFzL6m4rdTRDs130_assertion description "[EXPERIMENTAL TECHNIQUE: Immunostaining for pSTAT3, TGF-alpha, EGFR, and GRPR was done in two SCCHN cohorts (cohort 1, 61 tumors; cohort 2, 69 paired primary tumors and lymph node metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804315.RAqIHNJK_f1OXHT2VyycaFEzoDxwsOaJtFzL6m4rdTRDs130_provenance.
- assertion description "[EXPERIMENTAL TECHNIQUE: Immunostaining for pSTAT3, TGF-alpha, EGFR, and GRPR was done in two SCCHN cohorts (cohort 1, 61 tumors; cohort 2, 69 paired primary tumors and lymph node metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[EXPERIMENTAL TECHNIQUE: Immunostaining for pSTAT3, TGF-alpha, EGFR, and GRPR was done in two SCCHN cohorts (cohort 1, 61 tumors; cohort 2, 69 paired primary tumors and lymph node metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP658548.RAZgaN3eoJxqPUB1WQKw7qZeQtKOFBg7oYgwPneejR4L0130_assertion description "[EXPERIMENTAL TECHNIQUE: Immunostaining for pSTAT3, TGF-alpha, EGFR, and GRPR was done in two SCCHN cohorts (cohort 1, 61 tumors; cohort 2, 69 paired primary tumors and lymph node metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658548.RAZgaN3eoJxqPUB1WQKw7qZeQtKOFBg7oYgwPneejR4L0130_provenance.
- NP436451.RAmanpb5RAndPO9fMGuMdA5D0ulha-CHSzxwZLPmeexaA130_assertion description "[EXPERIMENTAL TECHNIQUE: Immunostaining for pSTAT3, TGF-alpha, EGFR, and GRPR was done in two SCCHN cohorts (cohort 1, 61 tumors; cohort 2, 69 paired primary tumors and lymph node metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436451.RAmanpb5RAndPO9fMGuMdA5D0ulha-CHSzxwZLPmeexaA130_provenance.